Comparison of the molecular profile of brain metastases from colorectal cancer and corresponding primary tumors.

about

Comparison of the molecular profile of brain metastases from colorectal cancer and corresponding primary tumors.

Item

http://www.wikidata.org/entity/Q38826084

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Comparison of the molecular pr ...... corresponding primary tumors.

@en

type

Item

label

Comparison of the molecular pr ...... corresponding primary tumors.

@en

prefLabel

Comparison of the molecular pr ...... corresponding primary tumors.

@en

P1476

Comparison of the molecular pr ...... corresponding primary tumors.

@en

P2093

Caterina Fontanella

http://www.w3.org/2001/XMLSchema#string

Federica E Pisa

http://www.w3.org/2001/XMLSchema#string

Francesco Tuniz

http://www.w3.org/2001/XMLSchema#string

Gianpiero Fasola

http://www.w3.org/2001/XMLSchema#string

Giovanna De Maglio

http://www.w3.org/2001/XMLSchema#string

Giuseppe Aprile

http://www.w3.org/2001/XMLSchema#string

Karim Rihawi

http://www.w3.org/2001/XMLSchema#string

Mariaelena Casagrande

http://www.w3.org/2001/XMLSchema#string

Stefano Pizzolitto

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostic Role of PIK3CA Mutation in Colorectal Cancer: Cohort Study and Literature Review

A genetic model for colorectal tumorigenesis

Systematic review: brain metastases from colorectal cancer--Incidence and patient characteristics

Concordant analysis of KRAS, BRAF, PIK3CA mutations, and PTEN expression between primary colorectal cancer and matched metastases

Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012

Multidisciplinary treatment of brain metastases derived from colorectal cancer incorporating stereotactic radiosurgery: analysis of 78 patients.

Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients.

PIK3CA activating mutation in colorectal carcinoma: associations with molecular features and survival.

BRAF codons 594 and 596 mutations identify a new molecular subtype of metastatic colorectal cancer at favorable prognosis.

P304

135-144

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FON-2016-0196

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Marta Bonotto

P577

2016-08-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27578453

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer